Shigeki Takemoto

Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study

Takashi Ishida, Tatsuro Joh, Naokuni Uike et al. · Journal of Clinical Oncology · 2012 · 649 citations · Full text

Medicine, Oncology, Pharmacology +17

Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins

Shigeki Takemoto, James C. Mulloy, Anna Cereseto et al. · Proceedings of the National Academy of Sciences · 1997 · 276 citations

Life Sciences, Molecular Biology, Oncology +17

Dose‐intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T‐cell leukaemia‐lymphoma: a randomized phase <scp>II</scp> study

Takashi Ishida, Tatsuro Jo, Shigeki Takemoto et al. · British Journal of Haematology · 2015 · 262 citations · Full text

Medicine, Oncology, Pharmacology +17

Oridonin, a diterpenoid purified from<i>Rabdosia rubescens</i>, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-κB signal pathways

Takayuki Ikezoe, Yang Yang, Kentaro Bandobashi et al. · Molecular Cancer Therapeutics · 2005 · 151 citations · Full text

Medicine, Oncology, Pharmacology +15

Bcl-XL is up-regulated by HTLV-I and HTLV-II in vitro and in ex vivo ATLL samples

Christophe Nicot, Renaud Mahieux, Shigeki Takemoto et al. · Blood · 2000 · 105 citations

Life Sciences, Cell Biology, Molecular Biology +6